Performance of genotypic algorithms for predicting HIV-1 tropism measured against the enhanced-sensitivity trofile coreceptor tropism assay

Journal of Clinical Microbiology

Volumn 48, Issue 11, 2010, Pages 4135-4139

  Sánchez, Victoria ^a   Masiá, Mar ^a   Robledano, Catalina ^a   Padilla, Sergio ^a   Ramos, José Manuel ^a   Gutiérrez, Félix ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; BIOINFORMATICS; CD4 LYMPHOCYTE COUNT; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHENOTYPE; PLANT GROWTH; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYNCYTIUM; VIRUS GENE;

ADULT; AGED; ALGORITHMS; FEMALE; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RECEPTORS, HIV; SENSITIVITY AND SPECIFICITY; VIRAL TROPISM; VIRUS ATTACHMENT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78049514475     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01204-10     Document Type: Article

References (25)

1. Braun, P., and F. Wiesmann. 2007. Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals. Eur. J. Med. Res. 12:463-472.
2. Chueca, N., C. Garrido, M. Alvarez, E. Poveda, J. De Dios Luna, N. Zahonero, J. Hernández-Quero, V. Soriano, C. Maroto, C. De Mendoza, and F. García. 2009. Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools. J. Med. Virol. 81:763-767.
3. Delobel, P., M. T. Nugeyre, M. Cazabat, C. Pasquier, B. Marchou, P. Massip, F. Barre-Sinoussi, N. Israël, and J. Izopet. 2007. Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies. J. Clin. Microbiol. 45:1572-1580.
4. de Mendoza, C., C. Rodríguez, F. García, J. M. Eiros, L. Ruiz, E. Caballero, A. Aguilera, P. Leiva, J. Colomina, F. Gutierrez, J. Del Romero, J. Aguero, and V. Soriano on behalf of the Spanish HIV Seroconverter Study Group. 2007. Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance. J. Antimicrob. Chemother. 59:698-704.
5. Garrido, C., V. Roulet, N. Chueca, E. Poveda, A. Aguilera, K. Skrabal, N. Zahonero, S. Carlos, F. García, J. L. Faudon, V. Soriano, and C. de Mendoza. 2008. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes. J. Clin. Microbiol. 46:887-891.
6. Holguín, A., M. López, and V. Soriano. 2008. Reliability of rapid subtyping tools compared to that of phylogenetic analysis for characterization of human immunodeficiency virus type 1 non-B subtypes and recombinant forms. J. Clin. Microbiol. 46:3896-3899.
7. Hunt, P. W., P. R. Harrigan, W. Huang, M. Bates, D. W. Williamson, J. M. McCune, R. W. Price, S. S. Spudich, H. Lampiris, R. Hoh, T. Leigler, J. N. Martin, and S. G. Deeks. 2006. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia. J. Infect. Dis. 194:926-930.
8. Lengauer, T., O. Sander, S. Sierra, A. Thielen, and R. Kaiser. 2007. Bioinformatics predictions of HIV coreceptor usage. Nat. Biotechnol. 25:1407-1410.
9. Low, A. J., W. Dong, D. Chan, T. Sing, R. Swanstrom, R. Jensen, S. Pillai, B. Good, and P. R. Harrigan. 2007. Current V3 genotyping algorithms are inadequate for predicting X4 coreceptor usage in clinical isolates. AIDS 21:F17-F24.
10. Low, A. J., L. C. Swenson, and P. R. Harrigan. 2008. HIV coreceptor phenotyping in the clinical setting. AIDS Rev. 10:143-151.
11. McGovern, R., W. Dong, X. Zhong, D. Knapp, A. Thielen, D. Chapman, M. Lewis, I. James, H. Valdez, and R. Harrigan. 2010. Population-based sequencing of the V3-loop is comparable to the enhanced sensitivity Trofile assay in predicting virologic response to maraviroc of treatment-naïve patients in the MERIT trial. Abstr. 17th Conf. Retrovir. Opportunistic Infect., abstr. 92.
12. Obermeier, M., A. Carganico, B. Bieniek, D. Schleehauf, S. Dupke, and K. Fischer. 2010. Tropism testing from proviral DNA analysis of a subgroup from the Berlin maraviroc cohort, abstr. 23. Abstr. 8th Eur. HIV Drug Resist. Workshop, Sorrento, Italy.
13. Philpott, S. M. 2003. HIV-1 coreceptor usage, transmission, and disease progression. Curr. HIV Res. 1:217-227.
14. Poveda, E., V. Briz, V. Roulet, M. González, J. Faudon, K. Skrabal, and V. Soriano. 2007. Correlation between a phenotypic assay and three bioinformatics tools for determining HIV co-receptor use. AIDS 21:1487-1490. (Pubitemid 46988013)
15. Poveda, E., E. Seclén, M. González, F. García, N. Chueca, A. Aguilera, J. J. Rodríguez, J. González-Lahoz, and V. Soriano. 2009. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists. J. Antimicrob. Chemother. 63:1006-1010.
16. Raymond, S., P. Delobel, M. Mavigner, M. Cazabat, C. Souyris, K. Sandres-Sauné, L. Cuzin, B. Marchou, P. Massip, and J. Izopet. 2008. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism. AIDS 22:11-16.
17. Reeves, J., D. Han, P. Hunt, Y. Liu, T. Wrin, W. Huang, S. Deeks, C. Petropoulos, J. Whitcomb, E. Coakley, and N. Parkin. 2007. Enhancements to the Trofile HIV coreceptor tropism assay enable reliable detection of CXCR4-using subpopulations at less than 1%, abstr. H-1026. 47th Annu. Intersci. Conf. Antimicrob. Agents Chemother. (ICAAC). American Society for Microbiology, Washington, DC.
18. Rose, J. D., A. M. Rhea, J. Weber, and M. E. Quiñones-Mateu. 2009. Current tests to evaluate HIV-1 coreceptor tropism. Curr. Opin. HIV AIDS 4:136-142.
19. Sánchez, V., M. Masiá, C. Robledano, S. Padilla, B. Lumbreras, E. Poveda, C. de Mendoza, V. Soriano, and F. Gutiérrez. 2010. A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters. Abstr. 17th Conf. Retrovir. Opportunistic Infect., abstr. M-253.
20. Sander, O., T. Sing, I. Sommer, A. J. Low, P. K. Cheung, P. R. Harrigan, T. Lengauer, and F. S. Domingues. 2007. Structural descriptors of gp120 loop for the prediction of HIV-1 coreceptor usage. PloS Comput. Biol. 3:e58.
21. Sierra, S., A. Thielen, S. Reuter, B. Jensen, S. Esser, and G. Faetkenheuer. 2010. Tropism determination and clinical outcome of 61 patients under maraviroc treatment, abstr. 20. Abstr. 8th Eur. HIV Drug Resist. Workshop, Sorrento, Italy.
22. Skrabal, K., A. J. Low, W. Dong, T. Sing, P. K. Cheung, F. Mammano, and P. R. Harrigan. 2007. Determining human immunodeficiency virus coreceptor use in a clinical setting: degree of correlation between two phenotypic assays and a bioinformatic model. J. Clin. Microbiol. 45:279-284.
23. Trinh, L., D. Han, W. Huang, T. Wrin, J. Larson, L. D. Kiss, E. Coakley, C. J. Petropoulos, N. T. Parkin, J. M. Whitcomb, and J. D. Reeves. 2008. Technical validation of an enhanced sensitivity Trofile HIV coreceptor tropism assay for selecting patients for therapy with entry inhibitors targeting CCR5. Antivir. Ther. 13:A128.
24. Van Lelyveld, S., J. Symons, A. Hoepelman, A. Stam, P. Van Ham, and M. Nijhuis. 2010. Correlation of clinical outcome of maraviroc treatment with different methods to determine HIV tropism: genotypic assay, MT-2 assay and Trofile, abstr. 41. Abstr. 8th Eur. HIV Drug Resist. Workshop, Sorrento, Italy.
25. Whitcomb, J. M., W. Huang, S. Fransen, K. Limoli, J. Toma, T. Wrin, C. Chappey, L. D. Kiss, E. E. Paxinos, and C. J. Petropoulos. 2007. Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrob. Agents Chemother. 51:566-575.